Bottom line
QAAHBX vs PRHSX: the short answer
QAAHBX (T. Rowe Price Health Sciences Portfolio) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both etfs.
PRHSX is cheaper at 0.83% vs 1.11% — a difference of $28 a year per $10,000 invested.
Over five years, PRHSX returned +4.2% a year vs +3.9% for QAAHBX.
Updated Nov 19, 2026
QAAHBX vs PRHSX side by side
| QAAHBX | PRHSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | T. Rowe Price | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.11% | 0.83% |
| Annual cost per $10k | $111 | $83 |
| 10-yr cost on $10k (prospectus) | $1,352 | $1,025 |
| Max front load | None | — |
| 12b-1 fee | 0.25% | — |
| 1-yr return | +17.8% | +17.7% |
| 5-yr return (annualized) | +3.9% | +4.2% |
| 10-yr return (annualized) | +8.7% | +9.1% |
| Best quarter | +23.4% | +23.5% |
| Worst quarter | −15.8% | −15.8% |
| Net assets (fund) | $751.7M | $11.9B |
| Number of holdings | 277 | 279 |
| Portfolio turnover | 65% | 62% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
24 of QAAHBX's top 25 holdings also appear in PRHSX's top 25.
| Holding | QAAHBX | PRHSX |
|---|---|---|
| Eli Lilly & Co | 14.06% | 14.28% |
| Johnson & Johnson | 6.64% | 6.63% |
| Unitedhealth Group Inc | 5.88% | 5.99% |
| Abbvie Inc | 5.12% | 5.10% |
| Merck & Co. Inc. | 4.00% | 4.01% |
| Gilead Sciences Inc | 2.79% | 2.82% |
| Thermo Fisher Scientific Inc | 2.53% | 2.52% |
| Vertex Pharmaceuticals Inc | 2.26% | 2.28% |
| Bristol-myers Squibb Co | 2.12% | 2.11% |
| Abbott Laboratories | 1.91% | 1.89% |
| Intuitive Surgical Inc | 1.89% | 1.87% |
| Amgen Inc | 1.80% | 1.82% |
| Stryker Corp | 1.78% | 1.78% |
| Elevance Health Inc | 1.54% | 1.53% |
| Danaher Corp | 1.44% | 1.43% |
Source: SEC Form N-PORT
QAAHBX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
FAQ
What is the difference between QAAHBX and PRHSX?
QAAHBX (T. Rowe Price Health Sciences Portfolio) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both etfs. PRHSX is cheaper at 0.83% vs 1.11% — a difference of $28 a year per $10,000 invested.
Which is cheaper, QAAHBX or PRHSX?
PRHSX has the lower expense ratio (0.83%).
Should I own both QAAHBX and PRHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.